Summary
This Form 8-K filed by Wells Fargo & Company on April 22, 2013, primarily serves to disclose the filing of exhibits related to a Registration Statement on Form S-3. The key event reported is the issuance of two types of Medium-Term Notes, Series K: one linked to the iShares® MSCI Emerging Markets Index Fund, and another linked to 3 Month LIBOR with a maturity date of April 22, 2016. The filing includes the forms of these Notes, as well as legal opinions from Faegre Baker Daniels LLP and Sullivan & Cromwell LLP regarding the Notes and associated tax matters.
Key Highlights
- 1Wells Fargo issued new Medium-Term Notes, Series K, on April 21, 2013.
- 2The issuance includes notes linked to the iShares® MSCI Emerging Markets Index Fund.
- 3Another series of notes is linked to 3 Month LIBOR and matures on April 22, 2016.
- 4This filing is to provide supporting documentation for a previously filed Registration Statement on Form S-3.
- 5Legal opinions from Faegre Baker Daniels LLP and Sullivan & Cromwell LLP concerning the Notes are included as exhibits.
- 6The filing also includes consents from the aforementioned legal firms.
Frequently Asked Questions
The primary purpose of this 8-K filing is to provide the Securities and Exchange Commission with the forms of new Medium-Term Notes, Series K, that Wells Fargo & Company has issued, along with related legal and tax opinions. These documents are being filed in connection with a prior Registration Statement on Form S-3.
Wells Fargo issued two types of Medium-Term Notes, Series K: one whose performance is tied to the iShares® MSCI Emerging Markets Index Fund, and another that is linked to the 3 Month LIBOR interest rate and matures on April 22, 2016.
The legal opinions from Faegre Baker Daniels LLP and Sullivan & Cromwell LLP provide legal counsel and assurance regarding the Notes. Sullivan & Cromwell LLP's opinion specifically addresses tax matters related to these Notes, which is crucial for investors understanding their tax implications.
No, this particular 8-K filing (Item 9.01) does not contain financial statements. It focuses solely on the disclosure of exhibits related to the issuance of new debt securities and associated legal opinions.